Leading Research into Head & Neck Cancer

Squamous carcinoma of the tongue

Oracle is funding a pathologist to work on a pioneering tongue cancer study under Dr Amen’s supervision.

Tag: Predictive tests | Past Projects

Predicative Tests
Summary

Dr Furrat Amen is a Consultant ENT, Head and Neck, and Thyroid Surgeon at Peterborough City Hospital and Addenbrooke’s Hospital in Cambridge. Oracle is funding a pathologist to work on a pioneering tongue cancer study under Dr Amen’s supervision.

The pathologist will look at tumour samples from patients who did and didn’t develop tongue cancer metastases to try and identify key molecules of interest (or ‘biomarkers’). If different biomarkers are found to exist between the samples with and without metastases, clinicians could then stratify patients according to the biomarkers in their tumour. This could then allow patients to receive personalised treatments tailored to their cancer. Those in whom prolonged survival is expected could receive standard treatment and those in whom shortened survival is expected could receive more experimental or aggressive therapies.

Publications

Help us beat cancer

Our life-saving work relies on the money you give us.

Donate now and together we can save more lives by beating cancer sooner.

Dr Furrat Amen
Dr Furrat Amen

Project type:
Study

Project Leader:
Dr Furrat Amen

Researcher:
-

Commencement date:
-

Length of project:
-

Funding provided:
-

Funder:
-

Location:
Peterborough City Hospital and Addenbrooke’s Hospital in Cambridge

Follow us

Get in touch

Call 020 3875 8991

Email info@oraclecancertrust.org

Registered-logos-grey

Oracle Cancer Trust is a registered charity in England and Wales (1142037). A company limited by guarantee. Registered company in England and Wales (7125497). Registered address: 10 Parsons Green House, 27 Parsons Green Lane, London SW6 4HH.